Why oh why do we need you and others having to guess, interpret and embellish the sparse information from the company. All shareholders want, is accurate information that explains in Grade 3 English what the issues are.
Is the test not what it's cracked up to be? Is the reader dodgy? Is the data collection and reporting capability of the reader a problem. Is there something wrong with the colour of the EuGeni packaging? Is it so bloody good that more clinical trials need to be run to confirm its gold standard claim?
Point is, we don't know and todays "communication" didn't make it any clearer.
I've been a supporter of the company for a long time but I'm now on the sidelines until there is some actual clarity about the company's prospects. Too many unrealised and protracted collaborations and missed timelines and now the company is on its 3rd go at gaining TGA approval. Throw in the lack of any decent sales out of Europe since CE approval almost 10 months ago and I struggle to see a reason to hold anymore.
GLTA
- Forums
- ASX - By Stock
- ADO
- Ann: TGA Registration Update
Ann: TGA Registration Update, page-325
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
-0.003(10.3%) |
Mkt cap ! $64.73M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 2.6¢ | $209.8K | 7.543M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 592714 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 269442 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 592714 | 0.026 |
8 | 1513341 | 0.025 |
9 | 1391573 | 0.024 |
3 | 1165217 | 0.023 |
5 | 316454 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 269442 | 1 |
0.029 | 130000 | 1 |
0.030 | 32000 | 1 |
0.031 | 100000 | 1 |
0.032 | 450000 | 3 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online